Consistent with this notion, Benezra’s group first induced lung tumors in mice via lung-specific doxycycline-mediated oncogenic K-RAS activation; then, by shutting down the K-RAS expression, they created a condition that mimics oncogene withdrawal and resulted in tumor shrinkage and remission. This evidence concerns the gene KRAS and neoplasm.